Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Jiangsu Hengrui Pharmaceuticals
Jiangsu Hengrui Pharmaceuticals
Kailera reports Zepbound-rivaling weight loss in phase 2 obesity trial
Fierce Biotech
Mon, 01/13/25 - 11:01 am
Kailera Therapuetics
obesity
clinical trials
Jiangsu Hengrui Pharmaceuticals
Elevar, Hengrui eye quick refile for PD-1 liver cancer combo after surprise FDA rejection
Fierce Pharma
Wed, 07/10/24 - 11:06 am
Elevar Therapeutics
Jiangsu Hengrui Pharmaceuticals
PD-1 agonists
camrelizumab
rivoceranib
liver cancer
FDA
Few signs of gout pipeline flaring up
EP Vantage
Thu, 05/18/23 - 10:45 am
gout
Selecta Biosciences
Sobi
SEL-212
3SBio
Amgen
Arthrosi Therapeutics
Atom Bioscience
Dyve Biosciences
Hinova Pharmaceuticals
Horizon Therapeutics
InventisBio
Jiangsu Hengrui Pharmaceuticals
JW Group
LG Chem
Olatec Therapeutics
Shanton Bioscience
